[HTML][HTML] Immunogenicity and antibody persistence of diphteriatetanus-acellular pertussis vaccination in adolescents and adults: a systematic review of the literature …

R Squeri, C Genovese - J Prev Med Hyg, 2021 - ncbi.nlm.nih.gov
Materials and methods We prepared a review according to the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) with the aims of: a) describing the …

[HTML][HTML] Immunogenicity and antibody persistence of diphteria-tetanus-acellular pertussis vaccination in adolescents and adults: A systematic review of the literature …

R Squeri, C Genovese - Journal of Preventive Medicine and …, 2020 - ncbi.nlm.nih.gov
Materials and methods We prepared a review according to the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) with the aims of: a) describing the …

Duration of pertussis immunity after DTaP immunization: a meta-analysis

A McGirr, DN Fisman - Pediatrics, 2015 - publications.aap.org
BACKGROUND AND OBJECTIVES: Pertussis incidence is increasing, possibly due to the
introduction of acellular vaccines, which may have decreased the durability of immune …

Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a …

P Pitisuttithum, K Chokephaibulkit… - The Lancet Infectious …, 2018 - thelancet.com
Background The immunogenicity of acellular pertussis vaccines and persistence of immunity
after vaccination might be improved by using genetically inactivated pertussis toxin (PTgen) …

[HTML][HTML] Systematic review of immunogenicity and duration of immunity of currently licensed pertussis wP vaccines in children

AM Bagattini, MM Quarti… - Gates Open …, 2022 - gatesopenresearch.org
Background: Currently recommended whole cell pertussis (wP) vaccination schedule for
children includes a 3-dose primary schedule, and at least one booster dose. When …

Reactogenicity and immunogenicity of reduced antigen content diphtheria–tetanus–acellular pertussis vaccines as a booster in 4–7-year-old children primed with …

R Dagan, K Igbaria, L Piglansky, F Van Brusteghem… - Vaccine, 1999 - Elsevier
Background. The recent introduction of acellular pertussis vaccines (Pa) offers the possibility
of booster doses in older children and adults. This can be conveniently accomplished by …

Safety and immunogenicity of tetanus-diphtheria-acellular pertussis vaccine administered to children 10 or 11 years of age

GS Marshall, V Pool, DP Greenberg… - Clinical and Vaccine …, 2014 - Am Soc Microbiol
Boosting immunity to tetanus, diphtheria, and pertussis through the use of Tdap vaccines is
routinely recommended at 11 to 12 years of age; some states, however, require Tdap for …

Protective effect of contemporary pertussis vaccines: a systematic review and meta-analysis

TR Fulton, VK Phadke, WA Orenstein… - Clinical Infectious …, 2016 - academic.oup.com
Background. Acellular pertussis (aP) and whole-cell (wP) pertussis vaccines are presumed
to have similar short-term (< 3 years after completion of the primary series) efficacy …

[HTML][HTML] Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial

F Martinón-Torres, SA Halperin, T Nolan, B Tapiéro… - Vaccine, 2021 - Elsevier
Background Transplacentally transferred antibodies induced by maternal pertussis
vaccination interfere with infant immune responses to pertussis primary vaccination. We …

The effectiveness and safety of pertussis booster vaccination for adolescents and adults: A systematic review and meta-analysis

J Xu, S Liu, Q Liu, R Rong, W Tang, Q Wang, S Kuang… - Medicine, 2019 - journals.lww.com
Background: Due to the resurgence of pertussis, many countries have revised the pertussis
immunization schedules and recommended booster doses of pertussis component vaccine …